Karolinska Institutet, Karolinska University Hospital
Stockholm, 17176, Sweden
Location status: Recruiting
NCT Number: NCT04917471
To investigate the effect of nitrate supplementation on red blood cell function in patients with type 2 diabetes.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Stockholm, 17176, Sweden
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Type 2 diabetes
Exclusion criteria
Acute coronary syndrome Vegetarian diet Impaired renal function Absolute indication for proton pump inhibitor Ongoing treatment with organic nitrate Heart failure (ejection fraction <35%) Any condition that interferes with the possibility to fulfill the study protocol
70 ml bid
70 ml bid
Time frame: 1 week
Red blood cells are administered to an isolated rodent heart subjected to 25 min global ischemia and 60 min reperfusion. The percentage recovery during reperfusion is determined.
Contact information is provided by the study sponsor or research team.
Karolinska Institutet
Other
The Effect of Dietary Nitrate Supplementation on Red Blood Cell Function in Patients with Type 2 Diabetes
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07318207
Diabetes Mellitus, Diabetes Mellitus, Type 2
Lexington, Kentucky, United States
View Trial DetailsNCT06730113
Body Weight, Cardiovascular Diseases
Washington D.C., District of Columbia, United States
View Trial DetailsNCT07032844
Diabetes Mellitus, Diabetes Mellitus, Type 2
Birmingham, Alabama, United States
View Trial DetailsNCT06067399
Diabetes Mellitus, Diabetes Mellitus, Type 2
Al Khārjah, Egypt
View Trial Details